MedPath

Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder

Phase 2
Conditions
Female Sexual Arousal Disorder
Interventions
Drug: Placebo
Registration Number
NCT04948151
Lead Sponsor
Strategic Science & Technologies, LLC
Brief Summary

This study is looking to minimize side effects, while maintaining and potentially improving the therapeutic benefit to patients suffering from Female Sexual Arousal Disorder by providing a topical preparation of Sildenafil locally to the vulvar-vaginal tissue.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
440
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo CreamPlacebo-
Sildenafil Cream, 3.6%Sildenafil-
Primary Outcome Measures
NameTimeMethod
SFQ28 (AS) - 28 Day RecallSFQ28 score at the end of the Single-Blind Placebo Run-In to the end of the 12-Week Double-blind Dosing period.

Evaluating the efficacy of Sildenafil Cream, 3.6% measured by change from baseline to end of study in the Arousal-Sensation Domain of the SFQ28.

FSDS-DAO (Q14) - 28 Day RecallQ14 score at the end of the Single-Blind Placebo Run-In to the end of the 12-Week Double-blind Dosing period.

Evaluating the efficacy of Sildenafil Cream, 3.6% measured by change from baseline to end of study in the score for feeling concerned by difficulties with sexual arousal - Item #14 only of the FSDS-DAO.

Secondary Outcome Measures
NameTimeMethod
Arousal Diary (SSE)measured by daily prompt within 24hrs after each sexual event during the Single-Blind Placebo Run-In compared to the last 4 weeks of the Double-Blind Dosing Period.

Evaluating the efficacy of Sildenafil Cream, 3.6% measured by change from baseline to end of study in the number of Satisfactory Sexual Events, question #11 in teh ARousal Diary.

Trial Locations

Locations (51)

Coastal Clinical Research

🇺🇸

Mobile, Alabama, United States

Precision Clinical Trials-Arizona

🇺🇸

Phoenix, Arizona, United States

Visions Clinical Research -Tucson

🇺🇸

Tucson, Arizona, United States

Collaborative Neuroscience Network

🇺🇸

Garden Grove, California, United States

NRC Research Institute

🇺🇸

Orange, California, United States

Medical Center for Clinical Research - San Diego

🇺🇸

San Diego, California, United States

Schuster Medical Research Institute

🇺🇸

Sherman Oaks, California, United States

Downtown Women's Healthcare

🇺🇸

Denver, Colorado, United States

Coastal Connecticut Research, LLC

🇺🇸

New London, Connecticut, United States

Intimmedicine Specialists

🇺🇸

Washington, District of Columbia, United States

Scroll for more (41 remaining)
Coastal Clinical Research
🇺🇸Mobile, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.